Merger Notification - Announcement according to § 10 Cartel Act
Adragos Pharma Intellectual Property GmbH; Sanofi Winthrop Industrie
BWB/Z-7182
On 18.12.2025 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
The contemplated transaction concerns the acquisition of Sanofi's manufacturing, packaging and supplying site located in Maisons-Alfort in France by Adragos Pharma MAF Holding Intellectual Property GmbH (or one of its French affiliates), from SWI Winthrop Industrie, as well as the transfer to Adragos of related assets and liabilities, including the transfer to Adragos of the employees working on this site.
ÖNACE Codes: Manufacture of basic pharmaceutical products and pharmaceutical preparations.
C - MANUFACTURING C 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 15.01.2026.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 16.01.2026 .